Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
5.24
-0.08 (-1.50%)
At close: Aug 14, 2025, 4:00 PM
5.25
+0.01 (0.19%)
After-hours: Aug 14, 2025, 4:00 PM EDT

Entrada Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-73.3565.63-6.69-94.62-51.16-26.52
Upgrade
Depreciation & Amortization
3.913.772.841.91.120.33
Upgrade
Loss (Gain) From Sale of Assets
----0.070.02
Upgrade
Loss (Gain) From Sale of Investments
-8.02-10.02-5.780.15--
Upgrade
Stock-Based Compensation
19.717.9213.119.92.530.33
Upgrade
Change in Accounts Receivable
6.492.2-5.88---
Upgrade
Change in Accounts Payable
0.30.99-2.815.29-0.720.63
Upgrade
Change in Unearned Revenue
-69.97-119.81139.98---
Upgrade
Change in Income Taxes
-4.11-3.364.02---
Upgrade
Change in Other Net Operating Assets
1.181.121-16.4-2.71-0.35
Upgrade
Operating Cash Flow
-123.87-41.56139.8-93.79-50.86-25.57
Upgrade
Capital Expenditures
-2.69-3.16-5.61-2.89-4.58-2.32
Upgrade
Investment in Securities
11.71-24.64-132.78-145.76--
Upgrade
Investing Cash Flow
9.02-27.8-138.4-148.65-4.58-2.32
Upgrade
Issuance of Common Stock
2.08102.9621.040.48191.630.25
Upgrade
Financing Cash Flow
2.08102.9621.040.48307.4650.09
Upgrade
Net Cash Flow
-112.7733.6122.45-241.96252.0222.2
Upgrade
Free Cash Flow
-126.56-44.72134.19-96.67-55.44-27.89
Upgrade
Free Cash Flow Margin
-159.24%-21.21%104.01%---
Upgrade
Free Cash Flow Per Share
-3.09-1.154.06-3.09-8.85-25.23
Upgrade
Cash Income Tax Paid
4.624.6214.72---
Upgrade
Levered Free Cash Flow
-97.44-73.29149.04-58.56-36.26-17.21
Upgrade
Unlevered Free Cash Flow
-97.44-73.29149.04-58.56-36.26-17.21
Upgrade
Change in Working Capital
-66.1-118.85136.32-11.11-3.420.28
Upgrade
Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q